首页 > 最新文献

Journal of Pharmacopuncture最新文献

英文 中文
Satisfaction and Perceived Effectiveness on Herbal Decoctions for Postpartum Care: a cross-sectional survey of mother's experience. 产后护理中草药汤剂的满意度和感知效果:一项母亲经验的横断面调查。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.175
Min Kyung Hyun, Jang Kyung Park, Sung Yoon Oh

Objectives: In East Asia, postpartum care has traditionally been considered important for maternal health; however, studies on this are still insufficient. Therefore, we examined the satisfaction and perceived effectiveness of herbal decoctions used in postpartum care in a city in the Republic of Korea (ROK).

Methods: We analyzed anonymized secondary data obtained from a retrospective cross-sectional survey of women who had taken herbal decoctions provided by the support service for women giving birth in a local city in ROK. The questionnaire items consisted of basic information regarding childbirth, the need for the herbal decoction support service, satisfaction, and the effectiveness of the service received.

Results: A total of 68 women were included in the study, and those aged 30-39 accounted for 73.13%. Of the 68 women, 79.37% visited within 3 weeks of childbirth. Women's satisfaction regarding herbal decoction support for postpartum care was 76.47%, and most women (98.53%) responded that they needed it more than twice. More than 50% of women showed improvement in puerperal wind disorders, weight gain, and delayed eliminated lochia.

Conclusion: A large proportion of women who took herbal decoctions reported satisfaction and perceived effectiveness when used to treat puerperal wind disorders. Nevertheless, future well-designed clinical studies are needed to provide information on whether herbal decoctions effectively prevent and treat puerperal wind disorders.

目标:在东亚,产后护理传统上被认为对产妇保健很重要;然而,这方面的研究仍然不足。因此,我们调查了在韩国(韩国)一个城市的产后护理中使用草药煎剂的满意度和感知有效性。方法:我们对韩国某地方城市妇女分娩支持服务提供的草药煎剂的妇女进行回顾性横断面调查,并对匿名的二次数据进行分析。问卷内容包括分娩基本情况、对中药汤剂支持服务的需求、满意度和服务效果。结果:共纳入68名女性,年龄30-39岁占73.13%。在68名妇女中,79.37%在分娩后3周内就诊。女性对产后护理中草药汤剂支持的满意度为76.47%,大多数女性(98.53%)回答需要两次以上。超过50%的妇女表现出产褥期风障碍、体重增加和延迟消除恶露的改善。结论:服用中药煎剂治疗产褥期风病的妇女中,有相当大比例的妇女对中药煎剂的疗效满意。然而,未来需要精心设计的临床研究来提供草药煎剂是否有效预防和治疗产褥期风病的信息。
{"title":"Satisfaction and Perceived Effectiveness on Herbal Decoctions for Postpartum Care: a cross-sectional survey of mother's experience.","authors":"Min Kyung Hyun,&nbsp;Jang Kyung Park,&nbsp;Sung Yoon Oh","doi":"10.3831/KPI.2023.26.2.175","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.175","url":null,"abstract":"<p><strong>Objectives: </strong>In East Asia, postpartum care has traditionally been considered important for maternal health; however, studies on this are still insufficient. Therefore, we examined the satisfaction and perceived effectiveness of herbal decoctions used in postpartum care in a city in the Republic of Korea (ROK).</p><p><strong>Methods: </strong>We analyzed anonymized secondary data obtained from a retrospective cross-sectional survey of women who had taken herbal decoctions provided by the support service for women giving birth in a local city in ROK. The questionnaire items consisted of basic information regarding childbirth, the need for the herbal decoction support service, satisfaction, and the effectiveness of the service received.</p><p><strong>Results: </strong>A total of 68 women were included in the study, and those aged 30-39 accounted for 73.13%. Of the 68 women, 79.37% visited within 3 weeks of childbirth. Women's satisfaction regarding herbal decoction support for postpartum care was 76.47%, and most women (98.53%) responded that they needed it more than twice. More than 50% of women showed improvement in puerperal wind disorders, weight gain, and delayed eliminated lochia.</p><p><strong>Conclusion: </strong>A large proportion of women who took herbal decoctions reported satisfaction and perceived effectiveness when used to treat puerperal wind disorders. Nevertheless, future well-designed clinical studies are needed to provide information on whether herbal decoctions effectively prevent and treat puerperal wind disorders.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"175-183"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/6f/jop-26-2-175.PMC10315879.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Herbal Medicines on Lung Function in Asthma: a systematic review and meta-analysis of randomized controlled trials. 中药对哮喘患者肺功能的疗效:随机对照试验的系统回顾和荟萃分析。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.124
Alireza Derakhshan, Masoumeh Sadeghi, Amir-Mohammad-Hashem Asnaashari, Mohsen Dehghani, Roshanak Salari, Majid Khadem-Rezaiyan, Majid Mirsadraee, Shahin Saeidinejat, Shima Jalali, Shabnam Jalali

Objectives: The present study was designed to conduct a comprehensive systematic review and meta-analysis to assess the efficacy of herbal medicines as add-on therapy on lung function in asthmatic patients.

Methods: A comprehensive search of online databases was performed up to December 2021 to identify randomized controlled trials that used orally herbal preparations for asthma as add-on therapy. Studies were assessed for methodological quality using the Cochrane Collaboration's Risk of Bias tool. The main outcome was percent predicted value of forced expiratory volume (% predicted FEV1). Pooled weighted mean difference (WMD) estimate with corresponding 95% confidence interval (CI) was calculated using inverse-variance weights method while random effects meta-analysis was used, taking into account clinical and conceptual heterogeneity.

Results: As a result, 1,525 studies were identified. 169 studies were reviewed in-depth and 23 studies met our systematic review inclusion criteria. Finally, nine randomized controlled trials were included in the meta-analysis. Findings indicated that use of herbal medicines in patients with asthma significantly improved % predicted FEV1 (WMD 3.73, 95% CI 1.76-5.70), with no evidence for significant heterogeneity (p = 0.56 [Q statistic], I2 = 0.0%). In subgroup analysis by age, improvement in % predicted FEV1 was higher and significant in adults (WMD 5.16; 95% CI 2.68-7.63) compared to children (WMD = 1.27; 95% CI -1.98-4.51). Sensitivity analysis showed the significant effect of herbal medicine consumption on improving FEV1 was consistently (range of summary WMDs 3.27-4.59), indicating that the meta-analysis model was robust. There was no evidence of publication bias both visually and statistically.

Conclusion: Findings support, the complementary use of herbal medicines resulted in significant improvement in the lung function compared to standard treatment in asthmatic patients with no considerable adverse events. This improvement is more likely to be observed amongst adults.

目的:本研究旨在进行一项全面的系统评价和荟萃分析,以评估草药作为辅助治疗对哮喘患者肺功能的疗效。方法:对截至2021年12月的在线数据库进行全面检索,以确定使用口服草药制剂作为哮喘附加治疗的随机对照试验。使用Cochrane协作的偏倚风险工具评估研究的方法学质量。主要终点为用力呼气量预测值百分比(预测FEV1百分比)。考虑到临床和概念上的异质性,采用反方差权重法计算具有相应95%置信区间(CI)的合并加权平均差(WMD)估计值,同时采用随机效应荟萃分析。结果:1525项研究被确认。169项研究被深入审查,23项研究符合我们的系统审查纳入标准。最后,meta分析纳入了9个随机对照试验。结果显示,哮喘患者使用中草药可显著改善预测FEV1的% (WMD 3.73, 95% CI 1.76 ~ 5.70),无显著异质性(p = 0.56 [Q统计值],I2 = 0.0%)。在按年龄分组的亚组分析中,成人预测FEV1的改善率更高且显著(WMD为5.16;95% CI 2.68-7.63)与儿童相比(WMD = 1.27;95% ci -1.98-4.51)。敏感性分析显示,草药消费对改善FEV1的显著作用是一致的(总wmd范围为3.27-4.59),表明meta分析模型是稳健的。在视觉上和统计上都没有发表偏倚的证据。结论:研究结果支持,与标准治疗相比,补充使用草药可显著改善哮喘患者的肺功能,无明显不良事件。这种改善在成年人中更容易观察到。
{"title":"Efficacy of Herbal Medicines on Lung Function in Asthma: a systematic review and meta-analysis of randomized controlled trials.","authors":"Alireza Derakhshan,&nbsp;Masoumeh Sadeghi,&nbsp;Amir-Mohammad-Hashem Asnaashari,&nbsp;Mohsen Dehghani,&nbsp;Roshanak Salari,&nbsp;Majid Khadem-Rezaiyan,&nbsp;Majid Mirsadraee,&nbsp;Shahin Saeidinejat,&nbsp;Shima Jalali,&nbsp;Shabnam Jalali","doi":"10.3831/KPI.2023.26.2.124","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.124","url":null,"abstract":"<p><strong>Objectives: </strong>The present study was designed to conduct a comprehensive systematic review and meta-analysis to assess the efficacy of herbal medicines as add-on therapy on lung function in asthmatic patients.</p><p><strong>Methods: </strong>A comprehensive search of online databases was performed up to December 2021 to identify randomized controlled trials that used orally herbal preparations for asthma as add-on therapy. Studies were assessed for methodological quality using the Cochrane Collaboration's Risk of Bias tool. The main outcome was percent predicted value of forced expiratory volume (% predicted FEV1). Pooled weighted mean difference (WMD) estimate with corresponding 95% confidence interval (CI) was calculated using inverse-variance weights method while random effects meta-analysis was used, taking into account clinical and conceptual heterogeneity.</p><p><strong>Results: </strong>As a result, 1,525 studies were identified. 169 studies were reviewed in-depth and 23 studies met our systematic review inclusion criteria. Finally, nine randomized controlled trials were included in the meta-analysis. Findings indicated that use of herbal medicines in patients with asthma significantly improved % predicted FEV1 (WMD 3.73, 95% CI 1.76-5.70), with no evidence for significant heterogeneity (p = 0.56 [Q statistic], I<sup>2</sup> = 0.0%). In subgroup analysis by age, improvement in % predicted FEV1 was higher and significant in adults (WMD 5.16; 95% CI 2.68-7.63) compared to children (WMD = 1.27; 95% CI -1.98-4.51). Sensitivity analysis showed the significant effect of herbal medicine consumption on improving FEV1 was consistently (range of summary WMDs 3.27-4.59), indicating that the meta-analysis model was robust. There was no evidence of publication bias both visually and statistically.</p><p><strong>Conclusion: </strong>Findings support, the complementary use of herbal medicines resulted in significant improvement in the lung function compared to standard treatment in asthmatic patients with no considerable adverse events. This improvement is more likely to be observed amongst adults.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"124-138"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7f/a8/jop-26-2-124.PMC10315876.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on Acupuncture Efficiency in Human Polycystic Ovary/Ovarian Syndrome. 针刺治疗人多囊卵巢/卵巢综合征疗效研究进展
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.105
Natália M de Oliveira, Jorge Machado, Lara Lopes, Maria Begoña Criado

Objectives: Human Polycystic Ovary/Ovarian Syndrome (PCOS), a frequent endocrine pathophysiology among women of fertile age, is associated with woman's lifespan endocrine, metabolic and psychological implications. Long-term usage side effects of allopathic strategies and their low efficacy made complementary medicine treatments a relevant subject for these patients. The main aim of this work is to review the efficiency of the acupuncture treatment reported in the latest studies on literature regarding PCOS patients.

Methods: A comprehensive literature search, in English language, about the use of acupuncture on the management of PCOS, was conducted in October 2020 using EBSCO, Cochrane, PubMed, Medline, Embase, databases for randomised and non-randomised controlled trials between 2015 and 2020 (09/2015-10/2020), following the PRISMA protocol.

Results: This research led us to an analysis, according to PICOS, of six final papers selected among 178 in total. The articles addressed distinct aspects of the PCOS condition, diverse acupuncture techniques and different main and secondary outcomes in agreement to the respective main objective. According to this review, acupuncture seems to be useful for the treatment of this debilitating and chronic health condition which affects millions of women worldwide, many of them part of the workforce in their community.

Conclusion: Despite of the display of these positive results addressing acupuncture treatments to manage PCOS major symptoms - whether they are reproductive, metabolic, or mental health features - more research is urgent. Randomized, double blinded controlled trials with improved quality design and following STRICTA and/or CONSORT recommendations are necessary to engage acupuncture as a standardized and scientific validated technique in PCOS condition.

目的:人类多囊卵巢/卵巢综合征(PCOS)是育龄妇女中一种常见的内分泌病理生理,与女性一生的内分泌、代谢和心理相关。长期使用对抗疗法的副作用和低疗效使得补充药物治疗成为这些患者的相关课题。本文旨在对近年来文献报道的针灸治疗多囊卵巢综合征的疗效进行综述。方法:根据PRISMA协议,于2020年10月使用EBSCO、Cochrane、PubMed、Medline、Embase以及2015年至2020年(2015年9月至2020年10月)的随机和非随机对照试验数据库,对针灸在PCOS治疗中的应用进行全面的英文文献检索。结果:根据PICOS,我们从总共178篇论文中选择了6篇最终论文进行了分析。文章讨论了多囊卵巢综合征的不同方面,不同的针灸技术和不同的主要和次要结果,以符合各自的主要目标。根据这篇综述,针灸似乎对治疗这种使人衰弱的慢性健康状况有用,这种疾病影响着全世界数百万妇女,其中许多人是社区劳动力的一部分。结论:尽管针灸治疗在治疗多囊卵巢综合征主要症状(无论是生殖、代谢还是心理健康特征)方面显示了这些积极的结果,但仍需要更多的研究。改进质量设计并遵循STRICTA和/或CONSORT建议的随机、双盲对照试验是必要的,以使针灸成为PCOS条件下标准化和科学验证的技术。
{"title":"A Review on Acupuncture Efficiency in Human Polycystic Ovary/Ovarian Syndrome.","authors":"Natália M de Oliveira,&nbsp;Jorge Machado,&nbsp;Lara Lopes,&nbsp;Maria Begoña Criado","doi":"10.3831/KPI.2023.26.2.105","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.105","url":null,"abstract":"<p><strong>Objectives: </strong>Human Polycystic Ovary/Ovarian Syndrome (PCOS), a frequent endocrine pathophysiology among women of fertile age, is associated with woman's lifespan endocrine, metabolic and psychological implications. Long-term usage side effects of allopathic strategies and their low efficacy made complementary medicine treatments a relevant subject for these patients. The main aim of this work is to review the efficiency of the acupuncture treatment reported in the latest studies on literature regarding PCOS patients.</p><p><strong>Methods: </strong>A comprehensive literature search, in English language, about the use of acupuncture on the management of PCOS, was conducted in October 2020 using EBSCO, Cochrane, PubMed, Medline, Embase, databases for randomised and non-randomised controlled trials between 2015 and 2020 (09/2015-10/2020), following the PRISMA protocol.</p><p><strong>Results: </strong>This research led us to an analysis, according to PICOS, of six final papers selected among 178 in total. The articles addressed distinct aspects of the PCOS condition, diverse acupuncture techniques and different main and secondary outcomes in agreement to the respective main objective. According to this review, acupuncture seems to be useful for the treatment of this debilitating and chronic health condition which affects millions of women worldwide, many of them part of the workforce in their community.</p><p><strong>Conclusion: </strong>Despite of the display of these positive results addressing acupuncture treatments to manage PCOS major symptoms - whether they are reproductive, metabolic, or mental health features - more research is urgent. Randomized, double blinded controlled trials with improved quality design and following STRICTA and/or CONSORT recommendations are necessary to engage acupuncture as a standardized and scientific validated technique in PCOS condition.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"105-123"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/c7/jop-26-2-105.PMC10315877.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9802262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Health Insurance Data Analysis for the Second-Wave Development of Korean Medicine Clinical Practice Guidelines in South Korea. 国民健康保险数据分析在韩国第二波发展的韩国医学临床实践指南。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.198
Chan-Young Kwon, Seungwon Shin, O-Jin Kwon, Wonkyung Moon, Namkwen Kim, Minjung Park

Objectives: After the evidence-based Korean medicine clinical practice guidelines (KM-CPGs) for 30 targeted diseases were developed in 2021, 34 diseases have been proposed for the second-wave development of the KM-CPGs. The purpose of this study was to investigate the development priorities of the candidate diseases into the second-wave development of KM-CPGs in south Korea.

Methods: In this study, we analyzed the Health Insurance Review and Assessment Service National Patient Sample data from 2017 to 2018 to determine the demand and economic importance of the candidates for the second-wave development of KM-CPGs in real-world clinical settings in Korea.

Results: The annual number of visits and patients, annual healthcare expenditure per patient, and healthcare expenditure per institution were analyzed. Musculoskeletal disorders, including sciatica and adhesive capsulitis of the shoulder, were the most important topics regarding the number of visits and patients and annual healthcare expenditure per institution. Specifically, sciatica (52.05% of the total number of visits, 48.34% of the total number of patients, and 42.12% of the total treatment expenditure per institution) showed overwhelmingly high proportions. However, cerebral palsy (36.03% of the total number of inpatient visits and 24.55% of the total number of inpatient patients) was a more important topic in inpatient clinical settings than musculoskeletal conditions or cancer, and healthcare expenditure per patient in this topic had the highest ranking. Furthermore, fractures were found to be highly important in inpatient clinical settings. No patients had influenza A virus infection or posttraumatic stress disorders who visited the KM medical institution of interest.

Conclusion: This study highlights the gap between the real-world clinical setting and the research field in some topics. The results of this study can provide guidance for the second-wave development of KM-CPGs in the future.

▽目的:继2021年制定了针对30种目标疾病的循证韩国医学临床实践指南(KM-CPGs)之后,提出了针对34种疾病的第二次开发KM-CPGs。本研究旨在探讨韩国KM-CPGs第二波发展中候选疾病的发展重点。方法:在本研究中,我们分析了2017年至2018年健康保险审查和评估服务国家患者样本数据,以确定韩国现实世界临床环境中KM-CPGs第二波发展候选人的需求和经济重要性。结果:分析了年就诊人次和患者数、年人均医疗费用和单位医疗费用。肌肉骨骼疾病,包括坐骨神经痛和肩关节粘连性囊炎,是关于就诊人数和患者数量以及每家机构年度医疗保健支出的最重要主题。其中坐骨神经痛占就诊总次数的52.05%,占就诊总人数的48.34%,占医院总治疗费用的42.12%,比例极高。然而,脑瘫(占住院总人数的36.03%,占住院总人数的24.55%)是住院临床环境中比肌肉骨骼疾病或癌症更重要的话题,该话题的人均医疗保健支出排名最高。此外,骨折被发现是非常重要的住院病人的临床设置。没有患者有甲型流感病毒感染或创伤后应激障碍访问KM医疗机构感兴趣。结论:本研究突出了现实临床环境与研究领域在某些课题上的差距。本研究结果可为今后KM-CPGs的第二波发展提供指导。
{"title":"National Health Insurance Data Analysis for the Second-Wave Development of Korean Medicine Clinical Practice Guidelines in South Korea.","authors":"Chan-Young Kwon,&nbsp;Seungwon Shin,&nbsp;O-Jin Kwon,&nbsp;Wonkyung Moon,&nbsp;Namkwen Kim,&nbsp;Minjung Park","doi":"10.3831/KPI.2023.26.2.198","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.198","url":null,"abstract":"<p><strong>Objectives: </strong>After the evidence-based Korean medicine clinical practice guidelines (KM-CPGs) for 30 targeted diseases were developed in 2021, 34 diseases have been proposed for the second-wave development of the KM-CPGs. The purpose of this study was to investigate the development priorities of the candidate diseases into the second-wave development of KM-CPGs in south Korea.</p><p><strong>Methods: </strong>In this study, we analyzed the Health Insurance Review and Assessment Service National Patient Sample data from 2017 to 2018 to determine the demand and economic importance of the candidates for the second-wave development of KM-CPGs in real-world clinical settings in Korea.</p><p><strong>Results: </strong>The annual number of visits and patients, annual healthcare expenditure per patient, and healthcare expenditure per institution were analyzed. Musculoskeletal disorders, including sciatica and adhesive capsulitis of the shoulder, were the most important topics regarding the number of visits and patients and annual healthcare expenditure per institution. Specifically, sciatica (52.05% of the total number of visits, 48.34% of the total number of patients, and 42.12% of the total treatment expenditure per institution) showed overwhelmingly high proportions. However, cerebral palsy (36.03% of the total number of inpatient visits and 24.55% of the total number of inpatient patients) was a more important topic in inpatient clinical settings than musculoskeletal conditions or cancer, and healthcare expenditure per patient in this topic had the highest ranking. Furthermore, fractures were found to be highly important in inpatient clinical settings. No patients had influenza A virus infection or posttraumatic stress disorders who visited the KM medical institution of interest.</p><p><strong>Conclusion: </strong>This study highlights the gap between the real-world clinical setting and the research field in some topics. The results of this study can provide guidance for the second-wave development of KM-CPGs in the future.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"198-209"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/34/jop-26-2-198.PMC10315883.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of the Protective Effect of Citral, Silymarin, and Thymoquinone on Methotrexate-Induced Lung Injury in Rats. 柠檬醛、水飞蓟素和百里醌对甲氨蝶呤所致大鼠肺损伤的保护作用。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.184
Amani Sakineh, Mohammad Foad Noorbakhsh, Nasrollah Ahmadi, Nazifi Saeed, Barzan Behdokht

Objectives: Several studies have reported that methotrexate is an anti-cancer and immunosuppressive drug leading to lung injury. Therefore, the present study aimed to investigate the protective effects of silymarin, citral, and thymoquinone on methotrexate-induced pulmonary toxicity.

Methods: Forty-eight rats were divided into six groups, including healthy, Methotrexate, and drug carrier control groups and silymarin, citral, and thymoquinone treatment groups. At the end of the experiment, the studied rats were anesthetized and sacrificed by CO2. Lung tissue samples were isolated to measure the antioxidant activity and histopathological evaluation.

Results: In the thymoquinone treatment group, the concentration of total antioxidant capacity and Malondialdehyde increased and decreased significantly, respectively, compared to the methotrexate group. The histopathological evaluation of the lung of the methotrexate group showed hemorrhage and congestion, the nodule-like accumulation of mononuclear inflammatory lymphocytes around the blood vessel, a small number of neutrophils around the blood vessel, and the inflammatory cells around the small vessels. However, no significant pathological alterations were observed in the treatment groups, especially the thymoquinone treatment group.

Conclusion: Thymoquinone has the greatest protective effect on methotrexate-induced lung injury, probably due to its antioxidant effect.

目的:一些研究报道甲氨蝶呤是一种导致肺损伤的抗癌和免疫抑制药物。因此,本研究旨在探讨水飞蓟素、柠檬醛和百里醌对甲氨蝶呤所致肺毒性的保护作用。方法:48只大鼠分为健康组、甲氨蝶呤组、药物载体对照组和水飞蓟素、柠檬醛、百里醌治疗组。实验结束后,用CO2麻醉处死大鼠。分离肺组织样品,测定其抗氧化活性和组织病理学评价。结果:百里醌治疗组与甲氨蝶呤组相比,总抗氧化能力和丙二醛浓度分别显著升高和降低。甲氨蝶呤组肺组织病理学检查显示出血充血,血管周围单核炎性淋巴细胞结节样积聚,血管周围少量中性粒细胞,小血管周围有炎性细胞。而治疗组,尤其是百里醌治疗组未见明显病理改变。结论:百里醌对甲氨蝶呤所致肺损伤的保护作用最大,可能与其抗氧化作用有关。
{"title":"Evaluation of the Protective Effect of Citral, Silymarin, and Thymoquinone on Methotrexate-Induced Lung Injury in Rats.","authors":"Amani Sakineh,&nbsp;Mohammad Foad Noorbakhsh,&nbsp;Nasrollah Ahmadi,&nbsp;Nazifi Saeed,&nbsp;Barzan Behdokht","doi":"10.3831/KPI.2023.26.2.184","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.184","url":null,"abstract":"<p><strong>Objectives: </strong>Several studies have reported that methotrexate is an anti-cancer and immunosuppressive drug leading to lung injury. Therefore, the present study aimed to investigate the protective effects of silymarin, citral, and thymoquinone on methotrexate-induced pulmonary toxicity.</p><p><strong>Methods: </strong>Forty-eight rats were divided into six groups, including healthy, Methotrexate, and drug carrier control groups and silymarin, citral, and thymoquinone treatment groups. At the end of the experiment, the studied rats were anesthetized and sacrificed by CO<sub>2</sub>. Lung tissue samples were isolated to measure the antioxidant activity and histopathological evaluation.</p><p><strong>Results: </strong>In the thymoquinone treatment group, the concentration of total antioxidant capacity and Malondialdehyde increased and decreased significantly, respectively, compared to the methotrexate group. The histopathological evaluation of the lung of the methotrexate group showed hemorrhage and congestion, the nodule-like accumulation of mononuclear inflammatory lymphocytes around the blood vessel, a small number of neutrophils around the blood vessel, and the inflammatory cells around the small vessels. However, no significant pathological alterations were observed in the treatment groups, especially the thymoquinone treatment group.</p><p><strong>Conclusion: </strong>Thymoquinone has the greatest protective effect on methotrexate-induced lung injury, probably due to its antioxidant effect.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"184-191"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/82/d2/jop-26-2-184.PMC10315881.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9802264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Do Parents' Experiences Affect Children's Use of the Traditional Korean Medical Services? A Regression Analysis Using Cross-Sectional Data. 父母的经历如何影响儿童对韩国传统医疗服务的使用?使用横截面数据的回归分析。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-03-31 DOI: 10.3831/KPI.2023.26.1.67
Sungwon Lee, Jihye Kim

Objectives: Medical services are closely related to individual health and welfare, and health status in childhood or adolescence is widely recognized to be related to many socioeconomic outcomes. Therefore, providing appropriate medical services in childhood and adolescence is important. We aimed to investigate the determinants of traditional Korean medical services (TKMS) usage by children aged < 19 years. The focus was on the role of their parents' experiences with TKMS in determining TKMS use by children.

Methods: Using a representative sample in South Korea, we conducted a regression analysis to assess how parents' experience with TKMS affects the probability of their children using TKMS.

Results: We found parents' experience with TKMS to have a significantly positive effect on the probability of TKMS use by children and parents' biological information, such as age and sex, to affect the probability of TKMS use. Specifically, parents' experiences with TKMS generally increased the probability of children using TKMS by approximately 20%.

Conclusion: This study's results suggest that considering parents' opinions and providing them the opportunity to participate in programs that enhance young children's use of TKMS may be effective.

目的:医疗服务与个人健康和福利密切相关,儿童或青少年的健康状况被广泛认为与许多社会经济结果有关。因此,为儿童和青少年提供适当的医疗服务非常重要。我们的目的是调查19岁以下儿童使用传统韩国医疗服务(TKMS)的决定因素。研究的重点是父母使用TKMS的经历在决定儿童是否使用TKMS方面所起的作用。方法:使用韩国的代表性样本,我们进行了回归分析,以评估父母使用TKMS的经历如何影响其子女使用TKMS的概率。结果:我们发现父母使用TKMS的经历对儿童使用TKMS的概率有显著的正向影响,父母的生物信息,如年龄和性别,对TKMS的使用概率有影响。具体来说,父母使用TKMS的经历通常会使儿童使用TKMS的可能性增加约20%。结论:本研究的结果表明,考虑父母的意见,为他们提供参与项目的机会,以提高幼儿对TKMS的使用可能是有效的。
{"title":"How Do Parents' Experiences Affect Children's Use of the Traditional Korean Medical Services? A Regression Analysis Using Cross-Sectional Data.","authors":"Sungwon Lee,&nbsp;Jihye Kim","doi":"10.3831/KPI.2023.26.1.67","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.1.67","url":null,"abstract":"<p><strong>Objectives: </strong>Medical services are closely related to individual health and welfare, and health status in childhood or adolescence is widely recognized to be related to many socioeconomic outcomes. Therefore, providing appropriate medical services in childhood and adolescence is important. We aimed to investigate the determinants of traditional Korean medical services (TKMS) usage by children aged < 19 years. The focus was on the role of their parents' experiences with TKMS in determining TKMS use by children.</p><p><strong>Methods: </strong>Using a representative sample in South Korea, we conducted a regression analysis to assess how parents' experience with TKMS affects the probability of their children using TKMS.</p><p><strong>Results: </strong>We found parents' experience with TKMS to have a significantly positive effect on the probability of TKMS use by children and parents' biological information, such as age and sex, to affect the probability of TKMS use. Specifically, parents' experiences with TKMS generally increased the probability of children using TKMS by approximately 20%.</p><p><strong>Conclusion: </strong>This study's results suggest that considering parents' opinions and providing them the opportunity to participate in programs that enhance young children's use of TKMS may be effective.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 1","pages":"67-76"},"PeriodicalIF":1.4,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/74/jop-26-1-67.PMC10063421.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9234407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Chronic and Acute Toxicity of Traditional Medicines Containing Terminalia chebula. 含慈母的中药的慢性和急性毒性。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-03-31 DOI: 10.3831/KPI.2023.26.1.18
Arongqiqige, Gerelmaa Enebish, Wang Song, Wei Cheng Xi, Anuujin Gantumur, Oyunbaatar Altanbayar, Hirofumi Shimomura, Battogtokh Chimeddorj, Batnairamdal Chuluun, Avarzed Amgalanbaatar

Objectives: Terminalia chebula, the main ingredient of Altan Arur 5, has been used for many years in traditional medicine. This medicine is more effective than other drugs and is used to treat chronic gastritis and gastrointestinal disorders such as peptic ulcers and esophageal reflux. Other ingredients of Altan Arur 5 are Punica granatum (pomegranate), tulip seeds, black balm, and excreta of Trogopterus xanthipes. The main ingredients of T. chebula are antibacterial and analgesic in traditional medicine. Despite having been used for many years and although many studies have been conducted on the beneficial effects of this medicine and its ingredients, the toxicity of Altan Arur 5 has not yet been elucidated. Therefore, we aimed to study the toxicity of Altan Arur 5 to ensure that it is safe to use.

Methods: Acute and chronic toxicity of Altan Arur 5 were assessed in 10 Kunming mice and 8 Sprague-Dawley rats, respectively, in different doses. In the acute toxicity study, Altan Arur 5 was orally administered to Kunming mice in doses of 12 g/kg, 24 g/kg, and 48 g/kg for 14 days. In the chronic toxicity study, it was orally administered to Sprague-Dawley rats in doses of 1.25 g/kg, 2.5 g/kg, and 5 g/kg for 12 weeks.

Results: No significant differences were observed in the relative organ weights for mice treated with Altan Arur 5 compared with those in the control group. Furthermore, no macro- or microstructural changes were noted in the organs of any group.

Conclusion: Our toxicity testing revealed that the traditional medicine Altan Arur 5 has no toxic effects in vivo.

目的:丹参5的主要成分苦参在传统医学中已被使用多年。这种药比其他药物更有效,用于治疗慢性胃炎和胃肠道疾病,如消化性溃疡和食管反流。Altan Arur 5的其他成分是石榴(石榴),郁金香种子,黑香脂和Trogopterus xanthipes的排泄物。在传统医学中,板栗的主要成分是抗菌和镇痛。尽管已经使用了多年,尽管已经对这种药物及其成分的有益作用进行了许多研究,但Altan Arur 5的毒性尚未被阐明。因此,我们旨在研究Altan Arur 5的毒性,以确保其安全使用。方法:分别对10只昆明小鼠和8只Sprague-Dawley大鼠进行不同剂量的急性和慢性毒性试验。在急性毒性研究中,以12 g/kg、24 g/kg和48 g/kg的剂量给药昆明小鼠,持续14天。在慢性毒性研究中,以1.25 g/kg、2.5 g/kg和5 g/kg的剂量口服Sprague-Dawley大鼠12周。结果:与对照组相比,Altan arur5治疗小鼠的相对脏器重量无显著差异。此外,各组器官均未见宏观或微观结构变化。结论:我们的毒性试验表明,传统药物阿坦阿鲁尔5在体内没有毒性作用。
{"title":"The Chronic and Acute Toxicity of Traditional Medicines Containing <i>Terminalia chebula</i>.","authors":"Arongqiqige,&nbsp;Gerelmaa Enebish,&nbsp;Wang Song,&nbsp;Wei Cheng Xi,&nbsp;Anuujin Gantumur,&nbsp;Oyunbaatar Altanbayar,&nbsp;Hirofumi Shimomura,&nbsp;Battogtokh Chimeddorj,&nbsp;Batnairamdal Chuluun,&nbsp;Avarzed Amgalanbaatar","doi":"10.3831/KPI.2023.26.1.18","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.1.18","url":null,"abstract":"<p><strong>Objectives: </strong><i>Terminalia chebula</i>, the main ingredient of Altan Arur 5, has been used for many years in traditional medicine. This medicine is more effective than other drugs and is used to treat chronic gastritis and gastrointestinal disorders such as peptic ulcers and esophageal reflux. Other ingredients of Altan Arur 5 are <i>Punica granatum</i> (pomegranate), tulip seeds, black balm, and excreta of <i>Trogopterus xanthipes</i>. The main ingredients of <i>T. chebula</i> are antibacterial and analgesic in traditional medicine. Despite having been used for many years and although many studies have been conducted on the beneficial effects of this medicine and its ingredients, the toxicity of Altan Arur 5 has not yet been elucidated. Therefore, we aimed to study the toxicity of Altan Arur 5 to ensure that it is safe to use.</p><p><strong>Methods: </strong>Acute and chronic toxicity of Altan Arur 5 were assessed in 10 Kunming mice and 8 Sprague-Dawley rats, respectively, in different doses. In the acute toxicity study, Altan Arur 5 was orally administered to Kunming mice in doses of 12 g/kg, 24 g/kg, and 48 g/kg for 14 days. In the chronic toxicity study, it was orally administered to Sprague-Dawley rats in doses of 1.25 g/kg, 2.5 g/kg, and 5 g/kg for 12 weeks.</p><p><strong>Results: </strong>No significant differences were observed in the relative organ weights for mice treated with Altan Arur 5 compared with those in the control group. Furthermore, no macro- or microstructural changes were noted in the organs of any group.</p><p><strong>Conclusion: </strong>Our toxicity testing revealed that the traditional medicine Altan Arur 5 has no toxic effects in vivo.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 1","pages":"18-26"},"PeriodicalIF":1.4,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/d9/jop-26-1-18.PMC10063424.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9246836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of the Shugan Jieyu Capsule against Psychiatric Symptoms in Epilepsy: a protocol for systematic review and meta-analysis. 舒肝解郁胶囊对癫痫精神症状的疗效:系统评价和荟萃分析
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-03-31 DOI: 10.3831/KPI.2023.26.1.38
Sejin Kim, Yunna Kim, Seung-Hun Cho
Objectives Psychiatric symptoms in epilepsy are very common, and the most common symptoms are depression, insomnia, and anxiety. These symptoms not only lower the quality of life of epilepsy patients, but also elevate the risk of epileptic seizures. There are no specific criteria for the available antiepileptic drugs to ameliorate these symptoms in patients with epilepsy, and there is a lack of evidence to support the efficacy and safety of existing drugs. The Shugan Jieyu capsule (SJC) is a traditional herbal medicine composed of Acanthopanax senticosus and Hypericum perforatum and is reported to be effective in relieving psychiatric symptoms. The purpose of this study was to assess the efficacy of SJC as a treatment for psychiatric symptoms in epilepsy patients. Methods Electronic databases will be investigated for publications in English, Korean, Japanese, and Chinese. The participants of the study are epilepsy patients with psychiatric symptoms diagnosed using any validated criteria. All types of controls will be compared—placebo, conventional treatments, and no treatment—to groups treated with SJC or modified SJC. We will measure the degree of improvement in psychiatric symptoms and check epileptic symptoms, such as the frequency of seizures. The study selection and data extraction will be performed by two independent reviewers, who will also assess methodological quality using the risk-of-bias tool by Cochrane. We will use Review Manager software (RevMan) to carry out all statistical analyses. Results This systematic review and meta-analysis will be performed in accordance with the PRISMA-P statement. Conclusion This systematic review is the first study to assess the efficacy and safety of SJC for the treatment of psychiatric symptoms in epilepsy. We expect that this study will provide clinically applicable evidence for patients with epilepsy when selecting drug treatments.
目的:癫痫患者的精神症状非常普遍,最常见的症状是抑郁、失眠和焦虑。这些症状不仅降低了癫痫患者的生活质量,而且增加了癫痫发作的风险。现有抗癫痫药物改善癫痫患者这些症状的具体标准尚不明确,也缺乏证据支持现有药物的有效性和安全性。舒肝解郁胶囊(SJC)是一种由刺五加和贯叶连翘组成的传统中药,据报道具有缓解精神症状的作用。本研究的目的是评估SJC治疗癫痫患者精神症状的疗效。方法:将调查英文、韩文、日文和中文出版物的电子数据库。该研究的参与者是使用任何有效标准诊断出精神症状的癫痫患者。将所有类型的对照——安慰剂、常规治疗和不治疗——与SJC治疗组或改良SJC组进行比较。我们将测量精神症状的改善程度,并检查癫痫症状,如癫痫发作的频率。研究选择和数据提取将由两名独立的审稿人进行,他们还将使用Cochrane的偏倚风险工具评估方法学质量。我们将使用Review Manager软件(RevMan)进行所有的统计分析。结果:本系统评价和荟萃分析将按照PRISMA-P声明进行。结论:本系统综述首次评价了SJC治疗癫痫精神症状的有效性和安全性。我们期望本研究能为癫痫患者选择药物治疗提供临床应用依据。
{"title":"Effectiveness of the Shugan Jieyu Capsule against Psychiatric Symptoms in Epilepsy: a protocol for systematic review and meta-analysis.","authors":"Sejin Kim,&nbsp;Yunna Kim,&nbsp;Seung-Hun Cho","doi":"10.3831/KPI.2023.26.1.38","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.1.38","url":null,"abstract":"Objectives Psychiatric symptoms in epilepsy are very common, and the most common symptoms are depression, insomnia, and anxiety. These symptoms not only lower the quality of life of epilepsy patients, but also elevate the risk of epileptic seizures. There are no specific criteria for the available antiepileptic drugs to ameliorate these symptoms in patients with epilepsy, and there is a lack of evidence to support the efficacy and safety of existing drugs. The Shugan Jieyu capsule (SJC) is a traditional herbal medicine composed of Acanthopanax senticosus and Hypericum perforatum and is reported to be effective in relieving psychiatric symptoms. The purpose of this study was to assess the efficacy of SJC as a treatment for psychiatric symptoms in epilepsy patients. Methods Electronic databases will be investigated for publications in English, Korean, Japanese, and Chinese. The participants of the study are epilepsy patients with psychiatric symptoms diagnosed using any validated criteria. All types of controls will be compared—placebo, conventional treatments, and no treatment—to groups treated with SJC or modified SJC. We will measure the degree of improvement in psychiatric symptoms and check epileptic symptoms, such as the frequency of seizures. The study selection and data extraction will be performed by two independent reviewers, who will also assess methodological quality using the risk-of-bias tool by Cochrane. We will use Review Manager software (RevMan) to carry out all statistical analyses. Results This systematic review and meta-analysis will be performed in accordance with the PRISMA-P statement. Conclusion This systematic review is the first study to assess the efficacy and safety of SJC for the treatment of psychiatric symptoms in epilepsy. We expect that this study will provide clinically applicable evidence for patients with epilepsy when selecting drug treatments.","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 1","pages":"38-43"},"PeriodicalIF":1.4,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/87/jop-26-1-38.PMC10063419.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9246839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Study of a Patient with Trigger Finger after Conducting Pharmacopuncture according to the Progress. 根据进展进行药物穿刺后扳机指的病例分析。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-03-31 DOI: 10.3831/KPI.2023.26.1.99
Jeong Ho Huh, Dong Heon Lee, Jun Young Lee, Ju Hwa Jeong, Seok Hee Kim, Kyung Jin Lee, Tae Han Yook, Kyeong Han Kim

Our study purpose was to report the clinical application of five different pharmacopunctures (Sweet BV, Scolopendrae Corpus, Chukyu, Cervi Parvum Cornu, and Hominis Placenta) for trigger finger. A patient was admitted to Ba-reun-mom S Korean Medicine Clinic and diagnosed with trigger finger. Because the effects of each pharmacopuncture have been confirmed in various acute to chronic cases, we treated a patient diagnosed with trigger finger using pharmacopunctures Sweet BV and Scolopendrae Corpus at the acute phase, Chukyu pharmacopuncture at the acute to chronic phase, and pharmacopunctures Cervi Parvum Cornu and Hominis Placenta at the chronic phase. This case was measured and assessed by Quinnell's classification of triggering and visual analogue scale (VAS) scores. After treatment, the patient's fifth finger pain and function were improved. The VAS score decreased from 5 to 0. The Quinnell's classification of triggering score decreased from 2 to 0. This case indicated that a patient with trigger finger could be treated by five pharmacopuncture treatments according to the treatment regimen and disease progress.

我们的研究目的是报道五种不同药物穿刺术(Sweet BV、Scolopendrae Corpus、Chukyu、Cervi Parvum Cornu和Hominis胎盘)治疗扳机指的临床应用。一名患者被诊断为“扳机指”。由于每种药物穿刺在各种急慢性病例中的作用已经得到证实,因此我们在急性期使用Sweet BV和Scolopendrae Corpus药物穿刺,在急性到慢性期使用Chukyu药物穿刺,在慢性期使用Cervi Parvum Cornu和Hominis胎盘药物穿刺治疗1例确诊为扳机指的患者。采用Quinnell触发评分和视觉模拟评分(VAS)对该病例进行测量和评估。治疗后,患者的五指疼痛和功能得到改善。VAS评分由5分降至0分。触发评分从2分下降到0分。本病例提示扳机指患者可根据治疗方案及病情进展,采用五种药物穿刺治疗。
{"title":"Case Study of a Patient with Trigger Finger after Conducting Pharmacopuncture according to the Progress.","authors":"Jeong Ho Huh,&nbsp;Dong Heon Lee,&nbsp;Jun Young Lee,&nbsp;Ju Hwa Jeong,&nbsp;Seok Hee Kim,&nbsp;Kyung Jin Lee,&nbsp;Tae Han Yook,&nbsp;Kyeong Han Kim","doi":"10.3831/KPI.2023.26.1.99","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.1.99","url":null,"abstract":"<p><p>Our study purpose was to report the clinical application of five different pharmacopunctures (Sweet BV, Scolopendrae Corpus, Chukyu, Cervi Parvum Cornu, and Hominis Placenta) for trigger finger. A patient was admitted to Ba-reun-mom S Korean Medicine Clinic and diagnosed with trigger finger. Because the effects of each pharmacopuncture have been confirmed in various acute to chronic cases, we treated a patient diagnosed with trigger finger using pharmacopunctures Sweet BV and Scolopendrae Corpus at the acute phase, Chukyu pharmacopuncture at the acute to chronic phase, and pharmacopunctures Cervi Parvum Cornu and Hominis Placenta at the chronic phase. This case was measured and assessed by Quinnell's classification of triggering and visual analogue scale (VAS) scores. After treatment, the patient's fifth finger pain and function were improved. The VAS score decreased from 5 to 0. The Quinnell's classification of triggering score decreased from 2 to 0. This case indicated that a patient with trigger finger could be treated by five pharmacopuncture treatments according to the treatment regimen and disease progress.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 1","pages":"99-104"},"PeriodicalIF":1.4,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/0e/jop-26-1-99.PMC10063416.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9240910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Korean Medicine Online Program on Mental Health. 韩国医学心理健康在线项目的开发。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-03-31 DOI: 10.3831/KPI.2023.26.1.77
Hye In Jeong, Kyeong Han Kim

Objectives: The coronavirus disease 2019 has deteriorated mental health, particularly in mothers with elementary school children. Although the country has developed several health promotion programs to preserve mental health, no program has incorporated Korean medicine. Thus, this study focuses on developing vital Korean medicine mental health care programs.

Methods: The program follows the Korean medicine health promotion program principles. Guidelines, reports, research, and previous programs were analyzed to form interventions and lecture content.

Results: Pellets, hot packs, meditation, lavender oil, and green tea were selected as final intervention strategies. Mental health-related guidelines were analyzed to produce stress management lecture materials. In addition, an operational methods and evaluation tool manual was created.

Conclusion: We designed a health promotion program capitalizing on Korean medicine to improve mental health. This program will be assessed and accordingly improved through practical applications.

2019冠状病毒病导致心理健康状况恶化,尤其是有小学生的母亲。虽然该国制定了若干健康促进计划,以保持精神健康,但没有一个计划纳入韩国医学。因此,本研究的重点是发展至关重要的韩国医学心理保健计划。方法:本项目遵循韩国医学健康促进项目原则。对指南、报告、研究和以前的项目进行分析,形成干预措施和讲座内容。结果:选择微丸、热敷、冥想、薰衣草油和绿茶作为最终干预策略。分析心理健康指南,制作压力管理讲座材料。此外,还编写了一份业务方法和评价工具手册。结论:我们设计了一个健康促进计划,利用韩国医学来改善心理健康。该方案将通过实际应用进行评估和相应的改进。
{"title":"Development of a Korean Medicine Online Program on Mental Health.","authors":"Hye In Jeong,&nbsp;Kyeong Han Kim","doi":"10.3831/KPI.2023.26.1.77","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.1.77","url":null,"abstract":"<p><strong>Objectives: </strong>The coronavirus disease 2019 has deteriorated mental health, particularly in mothers with elementary school children. Although the country has developed several health promotion programs to preserve mental health, no program has incorporated Korean medicine. Thus, this study focuses on developing vital Korean medicine mental health care programs.</p><p><strong>Methods: </strong>The program follows the Korean medicine health promotion program principles. Guidelines, reports, research, and previous programs were analyzed to form interventions and lecture content.</p><p><strong>Results: </strong>Pellets, hot packs, meditation, lavender oil, and green tea were selected as final intervention strategies. Mental health-related guidelines were analyzed to produce stress management lecture materials. In addition, an operational methods and evaluation tool manual was created.</p><p><strong>Conclusion: </strong>We designed a health promotion program capitalizing on Korean medicine to improve mental health. This program will be assessed and accordingly improved through practical applications.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 1","pages":"77-85"},"PeriodicalIF":1.4,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/eb/45/jop-26-1-77.PMC10063415.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9240911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Pharmacopuncture
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1